<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141149">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01783483</url>
  </required_header>
  <id_info>
    <org_study_id>0712</org_study_id>
    <secondary_id>SLBlu</secondary_id>
    <nct_id>NCT01783483</nct_id>
  </id_info>
  <brief_title>An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery</brief_title>
  <acronym>SB</acronym>
  <official_title>An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery: A Prospective, Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biomet, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biomet, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate sternal bone healing following a full
      median sternotomy versus standard of care for sternal closure with wire cerclage. Additional
      outcomes on post-operative pain and analgesic usage, patient function and quality of life,
      and complications will also be collected.  A health economics study will also be conducted,
      in which cost and billing data will be collected from sites participating in this clinical
      study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rigid sternal fixation with the BIOMET SternaLock Blu Sternal Closure System may result in
      greater sternal stability that leads to superior sternal bone healing, less postoperative
      pain and narcotic usage, and improved functional outcomes compared to wire cerclage. The
      health economics analysis is an interesting component of this study, in which cost and
      billing data will be collected from participating sites and analyzed in terms of
      cost/effectiveness for patients and healthcare system.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Evaluation of sternal bone healing, as defined by CT scan assessment.</measure>
    <time_frame>3-month and 6-month post-op.</time_frame>
    <safety_issue>No</safety_issue>
    <description>CT scans done by an independent core facility will evaluate sternal bone healing with the following parameters:
Acquire axial images from the lung apices to the costophrenic sulci with the table increment or reconstruction interval equal to or less than the slice thickness. Capture the entire sternum. Slice thickness along the sternum should be at a high spatial resolution thru thin, contiguous image slices (0.8 - 0.9mm). Region scans superior and inferior to the sternum may be made at more customary image slices (3-10 mm) at investigator discretion. CT scans should be taken without contrast.
All scans should be obtained in the same suspended state of respiration when possible. Scans should be obtained thru the entire area of interest. The field of view should be optimized for each patient.
Do not use gantry tilt in scanning patients if possible.
Archive the entire study, preferably in DICOM format, to a removable medium.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>Baseline, Post-Op hospital stay, 3-week, 6-week, 3-month, 6-month and 12-month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Intensity and frequency of sternal pain will be assessed using 10 point scales in the following circumstances:
At rest
After 10 breaths
After ambulation
After forced coughing
Participants will be assessed for pain pre-op (baseline); for the duration of the hospital stay, an expected average of 5 days; at 3-week post-op; 6-week post-op; 3-month post-op, 6-month post-op and 12-month post-op</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Narcotic Usage</measure>
    <time_frame>Baseline, Surgery, ICU stay, General Floor Stay, Discharge, 3-week, 6-week, 3-month, 6-month and 12-month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain medication usage will be tabulated and recorded at each follow-up interval.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">236</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Angina Pectoris</condition>
  <condition>Cardiac Valve Disease</condition>
  <arm_group>
    <arm_group_label>Suture Wire</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The closure technique should be per surgeon and institutional preference, with documentation of the wiring technique including the wiring configuration and number of wires used.  A minimum of 6 wires that cross the midline sternotomy should be used (e.g. 6 simple wires, 3 double wires, 3 figure of 8 wires, etc.).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SternaLock Blu closure system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive treatment option for sternal closure with the SternaLock Blue closure system at a minimum of 2 &quot;X&quot; plates on the sternal body and 1 &quot;L&quot; plate (or equivalent) on the manubrium.  This technique is the standard configuration for this study, and is intended to ensure that at least 3 plates are used to achieve adequate fixation and stability, while allowing for variations in the plating configuration as a result of patient anatomy and surgeon preference.  Various Sternal Blu plates may be used on the manubrium as described below, as can an additional plate on the sternal body.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SternaLock Blue closure system</intervention_name>
    <description>SternaLock Blue closure system is a primary closure system plate-based</description>
    <arm_group_label>SternaLock Blu closure system</arm_group_label>
    <other_name>SternaLock, SternalBlu</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Suture Wire</intervention_name>
    <description>Closure system wire-based used to approximate the two halfs of the sternum following a median sternotomy.</description>
    <arm_group_label>Suture Wire</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing a full standard midline sternotomy as a result of a cardiac
             surgical procedure (i.e. coronary artery bypass graft (CABG) and/or valve replacement
             along with other cardiac surgical procedures)

          -  Patients admitted to the hospital the day of or the day before their scheduled
             surgical procedure

          -  Patients â‰¥ 18 years of age

          -  Patients with a BMI &lt; 40

        Exclusion Criteria:

        Pre-operative

          -  Patients with endstage renal failure who are on dialysis

          -  Patients with severe chronic obstructive pulmonary disease (COPD) (FEV1 &lt; 50% or
             patients on on-home oxygen)

          -  Patients on prescribed pre-operative narcotics

          -  Patients taking chronic steroids, biologics acting as immunosuppressants (e.g. Enbrel
             (etanercept), Humira (adalimumab), Remicade (infliximab), or chemotherapeutics (iv or
             oral chemotherapeutics for cancer).  Patients using a steroid inhaler for asthma
             should not be excluded.

          -  Patients with an active infection as defined by a positive culture

          -  Patients with foreign body sensitivity

          -  Patients with mental or neurologic conditions who are unwilling or incapable of
             following postoperative care instructions

          -  Patients defined within the New York Heart Association (NYHA) or Canadian
             Cardiovascular Society (CCS) functional Class IV for congestive heart failure: i.e.,
             patients with cardiac disease resulting in inability to carry on any physical
             activity without discomfort (CCS ; NYHA)

          -  Patients presenting emergent/salvage cardiac acuity as defined per the Society of
             Thoracic Surgeons (STS) guidelines: i.e., patients undergoing cardiopulmonary
             resuscitation en route to the operating room or prior to induction of anesthesia
             (STS)

          -  Patients unwilling or unable to return for follow-up

        Operative

          -  Patients requiring delayed sternotomy closure

          -  Patients with an off-midline sternotomy reducing the bony margin between a SternaLock
             screw body and an osteotomy to within 2mm or less

          -  Patients presenting intra-operative conditions that in the opinion of the treating
             surgeon would require or preclude the use of either wire cerclage or rigid fixation,
             or who are not able to be plated or wired per the protocol (e.g. patients who in the
             opinion of the surgeon have insufficient quantity of quality of sternal bone; redo
             sternotomy with excessive fibrous tissue)

          -  Use of non resorbable (beeswax) bonewax

          -  Intraoperative death prior to device placement
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith B Allen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Luke's Mid America and Vascular Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brian Hatcher, PhD</last_name>
    <phone>904-741-9442</phone>
    <email>brian.hatcher@biomet.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mauricia Buchannan, RN</last_name>
      <phone>904-953-9455</phone>
      <email>Buchannan.Mauricia@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Kevin Landolfo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Carssow</last_name>
      <phone>404-686-3357</phone>
      <email>katherine.lee.carssow@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Vinod H. Thourani, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Franciscan St. Francis Health</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46237</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Miller</last_name>
      <phone>317-893-1948</phone>
      <email>molly.miller@franciscanalliance.org</email>
    </contact>
    <investigator>
      <last_name>Marc W. Gerdisch, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Blanton, RN</last_name>
      <phone>502-587-4381</phone>
      <email>mary.blanton@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Kendra Grubb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>United Heart &amp; Vascular Clinic, United Hospital, part of Allina Health</name>
      <address>
        <city>St Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kari Thomas</last_name>
      <phone>651-241-2847</phone>
      <email>Kari.Thomas@allina.com</email>
    </contact>
    <investigator>
      <last_name>John F Grehan, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Mid America Heart and Vascular Institute</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul J Kennedy, RN</last_name>
      <email>pkennedy@saint-lukes.org</email>
    </contact>
    <contact_backup>
      <last_name>Keith Allen, MD</last_name>
      <email>kallen2340@aol.com</email>
    </contact_backup>
    <investigator>
      <last_name>Keith B. Allen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Lucca-Sussana</last_name>
      <phone>212-434-3734</phone>
      <email>Mluccasusa@NSHS.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory P Fontana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khady Ndour</last_name>
      <phone>212-342-8528</phone>
      <email>kn2323@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Yoshifumi Naka, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Kashem</last_name>
      <phone>215-707-9732</phone>
      <email>mohammed.kashem@tuhs.temple.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas S. Guy, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scott &amp; White Memorial Hospital</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina C Amlin</last_name>
      <phone>254-724-5710</phone>
      <email>Tamlin@sw.org</email>
    </contact>
    <investigator>
      <last_name>Basar Sareyyupoglu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.biomet.com/microfixation/getFile.cfm?id=3179&amp;rt=inline</url>
    <description>SternaLock Blu Primary Closure System Brochure</description>
  </link>
  <link>
    <url>http://www.biomet.com/microfixation/products.cfm?pdid=9&amp;majcid=37&amp;prodid=205</url>
    <description>SternaLock Blu Product Description</description>
  </link>
  <reference>
    <citation>Bennett-Guerrero E, Phillips-Bute B, Waweru PM, Gaca JG, Spann JC, Milano CA. Pilot study of sternal plating for primary closure of the sternum in cardiac surgical patients. Innovations (Phila). 2011 Nov;6(6):382-8. doi: 10.1097/IMI.0b013e318248fbda.</citation>
    <PMID>22436774</PMID>
  </reference>
  <reference>
    <citation>Casha AR, Yang L, Kay PH, Saleh M, Cooper GJ. A biomechanical study of median sternotomy closure techniques. Eur J Cardiothorac Surg. 1999 Mar;15(3):365-9.</citation>
    <PMID>10333037</PMID>
  </reference>
  <reference>
    <citation>Chou SS, Sena MJ, Wong MS. Use of SternaLock plating system in acute treatment of unstable traumatic sternal fractures. Ann Thorac Surg. 2011 Feb;91(2):597-9. doi: 10.1016/j.athoracsur.2010.07.083.</citation>
    <PMID>21256325</PMID>
  </reference>
  <reference>
    <citation>Raman J, Lehmann S, Zehr K, De Guzman BJ, Aklog L, Garrett HE, MacMahon H, Hatcher BM, Wong MS. Sternal closure with rigid plate fixation versus wire closure: a randomized controlled multicenter trial. Ann Thorac Surg. 2012 Dec;94(6):1854-61. doi: 10.1016/j.athoracsur.2012.07.085. Epub 2012 Oct 25.</citation>
    <PMID>23103010</PMID>
  </reference>
  <reference>
    <citation>Hirose H, Yamane K, Youdelman BA, Bogar L, Diehl JT. Rigid sternal fixation improves postoperative recovery. Open Cardiovasc Med J. 2011;5:148-52. doi: 10.2174/1874192401105010148. Epub 2011 Jul 4.</citation>
    <PMID>21760857</PMID>
  </reference>
  <reference>
    <citation>Neaman KC, Blount AL, Kim JA, Renucci JD, Hooker RL. Prophylactic sternal plating with pectoralis advancement flaps after sternotomy in patients with a history of chest irradiation. Interact Cardiovasc Thorac Surg. 2011 Mar;12(3):355-8. doi: 10.1510/icvts.2010.247262. Epub 2010 Dec 7.</citation>
    <PMID>21138917</PMID>
  </reference>
  <reference>
    <citation>Snyder CW, Graham LA, Byers RE, Holman WL. Primary sternal plating to prevent sternal wound complications after cardiac surgery: early experience and patterns of failure. Interact Cardiovasc Thorac Surg. 2009 Nov;9(5):763-6. doi: 10.1510/icvts.2009.214023. Epub 2009 Aug 26.</citation>
    <PMID>19710069</PMID>
  </reference>
  <reference>
    <citation>Lee JC, Raman J, Song DH. Primary sternal closure with titanium plate fixation: plastic surgery effecting a paradigm shift. Plast Reconstr Surg. 2010 Jun;125(6):1720-4. doi: 10.1097/PRS.0b013e3181d51292.</citation>
    <PMID>20517097</PMID>
  </reference>
  <reference>
    <citation>Shifrin DA, Sohn SM, Stouffer CW, Hooker RL, Renucci JD. Sternal salvage with rigid fixation in the setting of a massive mediastinal aortic pseudoaneurysm: a case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008 Oct;61(10):e17-20. Epub 2007 Nov 26. Review.</citation>
    <PMID>18033747</PMID>
  </reference>
  <reference>
    <citation>Raman J, Straus D, Song DH. Rigid plate fixation of the sternum. Ann Thorac Surg. 2007 Sep;84(3):1056-8.</citation>
    <PMID>17720442</PMID>
  </reference>
  <reference>
    <citation>Raman J, Song DH, Bolotin G, Jeevanandam V. Sternal closure with titanium plate fixation--a paradigm shift in preventing mediastinitis. Interact Cardiovasc Thorac Surg. 2006 Aug;5(4):336-9. Epub 2006 Apr 25.</citation>
    <PMID>17670585</PMID>
  </reference>
  <reference>
    <citation>Dickie SR, Dorafshar AH, Song DH. Definitive closure of the infected median sternotomy wound: a treatment algorithm utilizing vacuum-assisted closure followed by rigid plate fixation. Ann Plast Surg. 2006 Jun;56(6):680-5.</citation>
    <PMID>16721085</PMID>
  </reference>
  <reference>
    <citation>Song DH, Lohman RF, Renucci JD, Jeevanandam V, Raman J. Primary sternal plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg. 2004 Aug;26(2):367-72.</citation>
    <PMID>15296898</PMID>
  </reference>
  <reference>
    <citation>Song DH, Agarwal JP, Jeevanandam V. Rigid sternal fixation in the cardiac transplant population. J Thorac Cardiovasc Surg. 2003 Sep;126(3):896-7.</citation>
    <PMID>14502187</PMID>
  </reference>
  <reference>
    <citation>Pai S, Gunja NJ, Dupak EL, McMahon NL, Roth TP, Lalikos JF, Dunn RM, Francalancia N, Pins GD, Billiar KL. In vitro comparison of wire and plate fixation for midline sternotomies. Ann Thorac Surg. 2005 Sep;80(3):962-8.</citation>
    <PMID>16122464</PMID>
  </reference>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>May 1, 2014</lastchanged_date>
  <firstreceived_date>January 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CABG</keyword>
  <keyword>Valve replacement</keyword>
  <keyword>sternal closure</keyword>
  <keyword>midline sternotomy</keyword>
  <keyword>sternal plates</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
